Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Pancreatic Neoplasms 29Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 20Triple Negative Breast Neoplasms 15Lung Neoplasms 10Colorectal Neoplasms 8Neoplasm Metastasis 7Esophageal Squamous Cell Carcinoma 7Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Esophageal Neoplasms 5Ovarian Neoplasms 4Biliary Tract Neoplasms 4Head and Neck Neoplasms 3Gallbladder Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Pancreatic Ductal 3Vaccinia 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms by Site 2Neoplasms 2Locally Advanced Pancreatic Cancer 2Gastrointestinal Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Advanced Solid Tumors 2Adenocarcinoma 2Ureteral Neoplasms 1Thyroid Neoplasms 1Squamous Non-small Cell Lung Cancer 1

Interventions

pembrolizumab 25Paclitaxel 20Carboplatin 17Bevacizumab 12Specimen Handling 10Letrozole 10abemaciclib 7dostarlimab 6Taxes 6Blood Specimen Collection 6Medroxyprogesterone Acetate 5Magnetic Resonance Spectroscopy 5Fulvestrant 5Drug Therapy 5Doxorubicin 5Cisplatin 5Biopsy 5olaparib 4lenvatinib 4atezolizumab 4Radiotherapy 4Progestins 4Observation 4Nivolumab 4Megestrol Acetate 4Immunoglobulin G 4Gemcitabine 4trastuzumab deruxtecan 3palbociclib 3X-Rays 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Endometrial Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT06906341 2026-04-14

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Corcept Therapeutics

Phase 2 Recruiting
270 enrolled
Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

NCT05092373 2026-01-14

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

M.D. Anderson Cancer Center

Phase 1 Recruiting
43 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡